Breaking Georgia Teen Pleads Guilty to Illegally Carrying Firearm on Capitol Grounds Gulf of Maine Waters Show Slight Cooling, But Ecosystem Instability Persists, NOAA Report Finds Tragic Shooting at Bite of Seattle Food Festival Leaves Three Dead, Four Injured Cape Verde’s Sidny Lopes Cabral Wins 2026 FIFA World Cup Goal of the Tournament Text Messages Presented in Court in Murder Case of Celeste Rivas Hernandez

Monday July 27, 2026

Reporter

Ascletis Pharma Inc.

2Articles Published

5Communities Covered

Published Articles

Press Release

Ascletis Announces Once-Monthly Subcutaneously Administered GLP-1R/GIPR/GCGR Triple Peptide Agonist, ASC37, Demonstrated Superior Weight Loss in a Diet-Induced Obese Mouse Model

11 hours ago

Press Release

Ascletis Announces Oral Discussion of ASC36_35 FDC Preclinical Data Demonstrating Superior Weight Loss to Eloralintide/Tirzepatide Combination at the 62nd European Association for the Study of Diabetes (EASD) Annual Meeting

Jul 22